Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Incyte to Report First Quarter Financial Results


Incyte (Nasdaq:INCY) announced today that it has scheduled its first quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, April 30, 2024.

The schedule for the press release and conference call/webcast is as follows:
? Q1 2024 Press Release:

April 30, 2024 at 7:00 a.m. ET

? Q1 2024 Conference Call:

April 30, 2024 at 8:00 a.m. ET

? Domestic Dial-In Number:

877-407-3042

? International Dial-In Number: 201-389-0864
? Conference ID Number: 13745743

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13745743.

The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for ninety days.

About Incyte

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.


These press releases may also interest you

at 11:49
Philadelphia Jury Returns $10 Million Verdict Against Albert Einstein Medical Center for Deadly Surgery
Philadelphia injury attorney Leonard Hill, founder of Hill & Associates, P.C., represented the estate of Ellen Breen, who died following a minimally invasive surgery that went wrong. Hill's colleague Susan Ayres also assisted in representing the...

at 09:00
Recognize National Women's Health Week by Taking Care of Your Gut Microbiome With Gundry MD Total Restore
National Women's Health Week encourages women to prioritize their well-being through preventive care, healthy habits, and regular check-ups....

at 07:12
ZINZINO AB (PUBL): Zinzino acquires assets in Xeliss - strategic reinforcement in southern Europe and in the microalgae spirulina
Zinzino, the global health and wellness brand from Scandinavia, has acquired, through a business asset acquisition, the rights to the distributor database and associated customer register, inventory, and intellectual property of the Luxembourg-based...

at 05:53
Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira in China
Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated today that the National Medical Products Administration (NMPA) has accepted its new drug application (NDA) for the...

at 05:43
Second Opinion Expert Announces Strategic Relationship with KangarooHealth
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that it has entered into a strategic relationship with KangarooHealth, Inc. to improve patient health outcomes, as well as reduce the cost of delivering care by...

11 mai 2024
Fast-Growing Prior Authorization Software Company Announces Addition of Chief Revenue Officer
eBlu Solutions, a leading provider of innovative technology solutions for the specialty healthcare industry, is pleased to announce the addition of Doug Lawrence to the Executive Leadership team in the role of Chief Revenue Officer. "We're not just...

More news about Health...


News published on and distributed by: